Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Videos
Diagnostics
In Vitro Diagnostics
Return to: MDBR Home | Diagnostics | In Vitro Diagnostics | News
Search Refinements

In Vitro Diagnostics News

View news from other Medical Devices sectors:
361-375 of 2993 results
GE Healthcare acquires Swiss firm Biosafe Group
By MDBR Staff Writer
GE Healthcare has acquired Switzerland-based cell bioprocessing systems supplier, Biosafe Group, for an undisclosed sum.
Diagnostics > In Vitro Diagnostics > News
New microbroth dilution susceptibility plate supports EUCAST recommendations for Staphylococcus testing
A new microbroth dilution plate that meets EUCAST breakpoint recommendations for antimicrobial susceptibility testing (AST) of Staphylococcus spp. is now available, enabling microbiology laboratories to obtain true minimum inhibitory concentration (MIC) results for Gram positive organisms while meeting European AST standards.
Diagnostics > In Vitro Diagnostics > News
Cellex receives NIH grant to develop rapid test for detection of carbapenemase producing organisms
Avioq announced that Cellex has received a National Institutes of Health (NIH) grant for developing a rapid test named qCPO for detection of carbapenemase producing organisms (CPO).
Diagnostics > In Vitro Diagnostics > News
Crown Bioscience launches OmniScreen cell panel screening platform
By MDBR Staff Writer
Crown Bioscience, a wholly owned subsidiary of Crown Bioscience International, is announcing the launch of the OmniScreen cell panel screening platform, a new versatile cell line screening service for oncology drug discovery programs.
Diagnostics > In Vitro Diagnostics > News
Luminex wins FDA and CE-IVD mark approval for Aries M1 in vitro diagnostic system
By MDBR Staff Writer
Luminex has secured clearance from the US Food and Drug Administration (FDA) and CE-IVD status for its new Aries M1 in vitro diagnostic system.
Diagnostics > In Vitro Diagnostics > News
Bio-Techne to buy US firm Advanced Cell Diagnostics
By MDBR Staff Writer
Clinical diagnostic products manufacturer Bio-Techne has agreed to acquire US-based Advanced Cell Diagnostics (ACD) for $250m.
Diagnostics > In Vitro Diagnostics > News
Sysmex Inostics launches blood-based RAS biomarker test in Italy
By MDBR Staff Writer
Molecular diagnostic firm Sysmex Inostics has introduced the OncoBEAM RAS CRC test in Italy.
Diagnostics > In Vitro Diagnostics > News
Akers Biosciences completes clinical trial of PIFA/Chlamydia rapid assay
By MDBR Staff Writer
Health information technologies developer Akers Biosciences has completed a clinical trial in the US for rapid chlamydia test.
Diagnostics > In Vitro Diagnostics > News
ADL launches urine-based diagnostic test to detect precursor to colorectal cancer
By MDBR Staff Writer
Atlantic Diagnostic Laboratories (ADL) announced the official launch of PolypDx, a non-invasive urine-based diagnostic test for detection of adenomatous polyps, the precursor to colorectal cancer. It is estimated that there will be 134,490 new cases reported this year.
Diagnostics > In Vitro Diagnostics > News
Transplant Genomics enters collaboration with Mayo Clinic
By FBR Staff Writer
Transplant Genomics (TGI) is collaborating with the Mayo Clinic Center for Individualized Medicine to develop, validate and commercialize diagnostic tests enabling personalized immunosuppression for solid organ transplant recipients.
Diagnostics > In Vitro Diagnostics > News
LabCorp launches new companion diagnostic for non-small cell lung cancer
By MDBR Staff Writer
Laboratory Corporation of America Holdings announced today the availability of a new application for the companion diagnostic associated with the use of Tarceva® for the treatment of certain patients with non-small cell lung cancer (NSCLC).
Diagnostics > In Vitro Diagnostics > News
BioLegend enters license agreement with Sanquin for peptide-MHC assay technology
By MDBR Staff Writer
BioLegend announces that it has licensed from Sanquin Blood Supply Foundation a novel technology to study antigen-specific T cells.
Diagnostics > In Vitro Diagnostics > News
Roche's procalcitonin assay gets FDA approval for sepsis management
By MDBR Staff Writer
The US Food and Drug Administration (FDA) has granted 510(k) clearance for Roche's Elecsys BRAHMS PCT (procalcitonin) assay which will be used to aid in the management of sepsis risk.
Diagnostics > In Vitro Diagnostics > News
Rosetta Genomics receives approval from New York State for HEME FISH-based assays
By MDBR Staff Writer
Rosetta Genomics announces receipt of conditional approval from the New York State Department of Health (NYSDOH) for its multiple fluorescence in situ hybridization (FISH) tests for detection of amplifications or rearrangements of DNA in a number of hematologic cancers, such as leukemias, lymphomas and myelomas in order to form a diagnosis and/or to evaluate prognosis or remission of disease.
Diagnostics > In Vitro Diagnostics > News
AmoyDx ROS1 diagnostics test contributed to phase II clinical study of Crizotinib in lung cancer
By MDBR Staff Writer
Amoy Diagnostics announced that its AmoyDx ROS1 test successfully supported OxOnc Development LP (“OxOnc”) in the completion of a Phase II study of crizotinib (the “OxOnc Study”) in East Asian patients with ROS1-positive metastatic non-small cell lung cancer (NSCLC).
Diagnostics > In Vitro Diagnostics > News
361-375 of 2993 results